Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

G protein-coupled receptors as therapeutic targets for multiple sclerosis.
Clinical profile and aetiology of optic neuritis in Hospital Universiti Sains Malaysia--5 years review.
Intrathecal versus Oral Baclofen; a Matched Cohort Study of Spasticity, Pain, Sleep, Fatigue and Quality of Life.
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Silent aspiration and recovery from Dysphagia in a case of bickerstaff brainstem encephalitis.
Direct effects of secretory products of immune cells on neurons and glia.
T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients.
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
An unusual case of neurobrucellosis presenting as demyelination disorder.
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Post subthalamic area deep brain stimulation for tremors: a mini-review.
Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis.
Transglutaminase 2 and neuroinflammation.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
Immunohistochemical study of Krüppel-like factor 4 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis.
Astrogliosis During Acute and Chronic Cuprizone Demyelination and Implications for Remyelination.
New treatments for multiple sclerosis: at what long-term risk?
Moving to fingolimod from natalizumab in multiple sclerosis-reply.

Pages